5.6 C
Alba Iulia
Monday, August 10, 2020

Medical Practice Income (OTC: USAQ) has the potential to generate over $60M in annual recurring revenue

Must Read

TOP 4 Low Float Biotech Stocks To Consider Buying: ADiTx Therapeutics, Inc. (ADTX), USA Equities Corp. (USAQ), ARCA biopharma, Inc. (ABIO) and Cancer Genetics,...

ADiTx Therapeutics, Inc.(NASDAQ: ADTX), a life sciences company, focuses on developing nucleic acid (DNA)-based technologies to minimize rejection of...

TOP 4 Cyber Security Stocks Under Accumulation: Palo Alto Networks, Inc. (PANW), GlobeX Data Ltd. (SWISF), Fortinet, Inc. (FTNT) and Check Point Software Technologies...

Palo Alto Networks, Inc. (NYSE: PANW) provides security platform solutions worldwide. The company provides firewall appliances and software; Panorama,...

The Volatility in Cannabis Stocks is Luring a Growing Number of Investors Toward Hemp Naturals Inc. (OTC: HPMM)

High-flying and volatile cannabis stocks have caught the attention of both the Main street and Wall Street this year....

The healthcare industry is undergoing rapid transformations since a few years now. Various technological improvements have been witnessed in the segments including diagnosis and treatment options for chronic diseases.

Technology is changing customers’ experiences and how healthcare providers work. Over the years, healthcare platforms have reduced the hurdles faced by both patients and providers. Digital technologies enable more efficient care and greater access for everyone, including the most vulnerable populations: the elderly, chronically ill, low income and rural.

The U.S. IoT healthcare market is anticipated to hold majority of revenue share owing to the presence of highly advanced healthcare infrastructure coupled with the early adoption of sophisticated technologies.

Investors can thank health care stocks for a chunk of the stock market’s rally. Health-care stocks have been among the best performers since the market bottomed in March.

USA Equities Corp (OTC: USAQ)

On December 20, 2019 USA Equities Corp entered into and consummated a share exchange with the former stockholders of Medical Practice Income, Inc. (MPI), a Florida corporation. As a result of the Share Exchange, MPI became our wholly-owned-subsidiary. We are focused on value-based healthcare solutions, clinical informatics and algorithmic personalized medicine including digital therapeutics, behavior based remote patient monitoring, chronic care and preventive medicine. The Company’s intellectual properties, products and information service portfolio is directed towards prevention, early detection, management and reversal of cardio-metabolic and other chronic diseases. Our principle objectives are to develop proprietary software tools, devices, and approaches, providing more granular, timely, and specific clinical decision-making information for practicing physicians and other health care providers to address todays obese, diabetic and cardiovascular disease population and is located in West Palm Beach, Florida. For more information, visit www.MedicalPracticeIncome.com/discover.
Now more than ever, technology and machine learning is at the forefront of patient care. Medical Practice Income addresses prevention and reduces such conditions as cardiovascular disease, diabetes, metabolic syndrome, and obesity through its innovative mobile and cloud-based software platforms.
One of the company’s recent launch is QHSLab, a Software as a Service (SaaS) platform today.

The Quality Health Score Lab Expert System (QHSLab) provides physicians and other healthcare organizations an advanced platform to capture patient information and store it in a secure, electronic database. It is then intelligently filtered, analyzed, and processed according to specific algorithms, managing large quantities of data with accuracy and precision.

QHSLab will be brought to the marketplace through approximately 150 primary care practices in Florida. Physicians, nurse practitioners, and ancillary medical practice staff will be active users of this platform, utilizing its proprietary algorithm initially for selecting appropriate allergen immunotherapy treatment sets for their patient populations.

Primary care physicians are overwhelmed by the number of patients suffering from allergies. Allergies often signal other health related concerns, indicating an immune system that is going wrong. Doctors need easy-to-use, digital medicine solutions that save time and money, while delivering the right treatment to patients that need it. Through our AI-enhanced, physician-directed platform, QHSLab, we are increasing the primary care physicians ability to more effectively address the issues with their patients, while saving patients time and expensive visits to a specialist when not absolutely necessary,” said Troy Grogan, President and CEO of Medical Practice Income, Inc.

Fredric Pullen MD, FACS, an Allergy and Ear, Nose & Throat Specialist based in Palm Beach Gardens, FL and Professor of Otolaryngology at the University of Miami Miller School of Medicine, shared the following insight regarding QHSLab: “It’s so much easier for busy primary care physicians to have a software system that can automatically generate the patient’s allergy formulas for their appropriate immunotherapy, based on their allergy test results. It saves time and potential error which is a definite plus for non-allergy specialist doctors.”

There are over 450,000 primary care physicians, including licensed nurse practitioners, in the United States. Many are reporting higher rates of fatigue and burnout due to long hours, heavy patient caseloads, and declining practice revenue from a lack of healthcare reimbursements. Digital medicine applications are a critical component to delivering quality patient care and added revenue to the physician’s practice.

With the addition of QHSLab, not only will physicians be better equipped to treat patients, but they will also be able to sustain their practices with ongoing revenue through healthcare reimbursements, generating much needed new income per practice, per year.

Grogan also shared his vision for the future of QHSLab, “We already see future iterations of QHSLab that will prove exciting additions to this innovative software platform. We will be expanding our platform to help monitor and course-correct medical conditions beyond allergies such as hypertension, cardiovascular disease, prediabetes, metabolic syndrome, anxiety and arthritis for example. We will continue our mission of focusing on prevention, and patient wellness, while supporting the frontline of healthcare, the primary care physician. We recognize the significance of the primary care physician in the healthcare system, now more than ever.”

- Advertisement -

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -

Latest News

TOP 4 Low Float Biotech Stocks To Consider Buying: ADiTx Therapeutics, Inc. (ADTX), USA Equities Corp. (USAQ), ARCA biopharma, Inc. (ABIO) and Cancer Genetics,...

ADiTx Therapeutics, Inc.(NASDAQ: ADTX), a life sciences company, focuses on developing nucleic acid (DNA)-based technologies to minimize rejection of...

TOP 4 Cyber Security Stocks Under Accumulation: Palo Alto Networks, Inc. (PANW), GlobeX Data Ltd. (SWISF), Fortinet, Inc. (FTNT) and Check Point Software Technologies...

Palo Alto Networks, Inc. (NYSE: PANW) provides security platform solutions worldwide. The company provides firewall appliances and software; Panorama, a security management solution for...

The Volatility in Cannabis Stocks is Luring a Growing Number of Investors Toward Hemp Naturals Inc. (OTC: HPMM)

High-flying and volatile cannabis stocks have caught the attention of both the Main street and Wall Street this year. For investors ready to jump...

Businesses and Governments are Spending more on Cybersecurity Platforms, which is seeing Companies like GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) Benefit

Business owners and managers have never been more concerned with cybersecurity. Home networks are particularly vulnerable as they lack the fortifications of business networks,...

Top 3 Healthcare Stocks Weathering The Coronavirus Storm Right Now

Biotech stocks have continued to be market-leading targets for investors through the coronavirus stock market crash and rebound. Moderna, Inc. (NASDAQ: MRNA), USA Equities...
- Advertisement -

More Articles Like This

- Advertisement -